Grey Matter Neurosciences

Grey Matter Neurosciences is a Toronto-based company focused on neurotechnology and medical devices aimed at treating age-related brain disorders, particularly Alzheimer's disease. They specialize in portable, non-invasive focused ultrasound technology that allows for therapeutic brain stimulation without the need for drugs or invasive procedures. Their main product is an ultrasound headset designed to deliver transcranial focused ultrasound, which fine-tunes neural circuits deep in the brain. This device aims to enhance cognitive performance and memory in seniors, especially those with Alzheimer's. It is notable for not requiring real-time image guidance or patient immobilization, making it suitable for both clinical and home-based treatments. The company has licensed advanced technology from Sunnybrook Research Institute and has secured $14 million in seed financing to support the development of their ultrasound headset and clinical trials. Grey Matter Neurosciences is dedicated to providing a non-invasive, drug-free alternative for seniors facing cognitive challenges, with a goal of improving their quality of life.

• Employees 20